ABBV-221
ABBV-221 is an antibody drug conjugate (ADC) targeting EGFR that is being investigated to treat cancerous tumors.
* For research use only. Not for human or veterinary use.
Synonym
| Synonyms | ABBV-221; ABBV 221; ABBV221 |
|---|
Property
| Molecular Formula: | C16H20N6O3 |
|---|---|
| Molecular Weight | |
| Target: | EGFR inhibitor |
| Solubility | Soluble in DMSO, not in water |
| Purity | ≥95% |
| Storage | 3 years -20C powder |